Prot #SP‐1011‐005: Fluticasone propionate Oral Dispersible Tablet Formulation in Eosinophilic Esophagitis: A Randomized, Double‐blind, Placebo‐Controlled 24‐Week Induction Study of APT‐1011, followed by a Single‐arm Open‐label Extension, in Adult Subjects

  • Hirano, Ikuo (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date7/19/237/19/26

Funding

  • Everest Clinical Research Corporation (Prot #SP-1011-005 // Prot #SP-1011-005)
  • Ellodi Pharmaceuticals, L.P. (Prot #SP-1011-005 // Prot #SP-1011-005)